Table 3.
Characteristics of patients who underwent pancreatectomy with simultaneous hepatectomy stratified by types of procedures. One patient who underwent major pancreatectomy with major hepatectomy was excluded from comparison
| Minor pancreatectomy with minor hepatectomy (n = 89) | Major pancreatectomy with minor hepatectomy (n = 11) | Minor pancreatectomy with major hepatectomy (n = 30) | p-value | |
|---|---|---|---|---|
| Age (years) | 58 (46–63) | 59 (51–66) | 53 (44–66) | 0.71 |
| Female sex | 41 (46%) | 4 (36%) | 13 (43%) | 0.85 |
| White racea | 82 (93%) | 11 (100%) | 26 (90%) | 0.63 |
| Charlson Comorbidity Index | 7 (6–8) | 8 (7–8) | 7 (6–8) | 0.56 |
| Functional tumor | 16 (18%) | 3 (27%) | 7 (23%) | 0.56 |
| Hereditary cancer syndrome | 6 (6.7%) | 2 (18%) | 2 (6.7%) | 0.34 |
| Primary tumor size (mm) | 46 (29–70) | 40 (38–49) | 47 (31–74) | 0.79 |
| Ki-67 ≥3%a | 38 (86%) | 5 (71%) | 14 (82%) | 0.54 |
| Overall grade ≥2a | 60 (77%) | 6 (75%) | 19 (73%) | 0.93 |
| 10+ liver metastases | 48 (54%) | 3 (27%) | 19 (63%) | 0.12 |
| Largest liver lesion (mm) | 35 (20–60) | 22 (14–28) | 65 (56–107) | <0.001 |
| Extrahepatic disease | 6 (6.7%) | 0 (0.0%) | 5 (17%) | 0.19 |
| Follow up (months) | 48 (21–97) | 38 (19–72) | 53 (38–87) | 0.33 |
Categorical variables are shown as number (percentage) and continuous variables as median (interquartile range)
aPatients with missing information on race (n = 2), Ki-67 (n = 62), and grade (n = 18) were excluded from the respective analyses